News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,702 Results
Type
Article (52605)
Company Profile (177)
Press Release (585920)
Multimedia
Podcasts (78)
Webinars (9)
Section
Business (179346)
Career Advice (2719)
Deals (33044)
Drug Delivery (113)
Drug Development (78935)
Employer Resources (166)
FDA (16474)
Job Trends (15229)
News (316639)
Policy (32356)
Tag
Academia (2842)
Accelerated approval (6)
Adcomms (28)
Allergies (94)
Alliances (46420)
ALS (98)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (152)
Approvals (16431)
Artificial intelligence (285)
Autoimmune disease (28)
Automation (16)
Bankruptcy (341)
Best Places to Work (11574)
BIOSECURE Act (19)
Biosimilars (119)
Biotechnology (123)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (307)
Cancer (2383)
Cardiovascular disease (203)
Career advice (2292)
Career pathing (33)
CAR-T (168)
Cell therapy (460)
Cervical cancer (20)
Clinical research (64524)
Collaboration (896)
Company closure (2)
Compensation (258)
Complete response letters (30)
COVID-19 (2830)
CRISPR (47)
C-suite (259)
Cystic fibrosis (109)
Data (2294)
Decentralized trials (2)
Denatured (19)
Depression (55)
Diabetes (291)
Diagnostics (6436)
Digital health (19)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (123)
Drug pricing (117)
Drug shortages (29)
Duchenne muscular dystrophy (103)
Earnings (67514)
Editorial (47)
Employer branding (22)
Employer resources (146)
Events (86127)
Executive appointments (757)
FDA (17854)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (118)
Generative AI (25)
Gene therapy (341)
GLP-1 (823)
Government (4751)
Grass and pollen (6)
Guidances (149)
Healthcare (18747)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (145)
Indications (29)
Infectious disease (2990)
Inflammatory bowel disease (146)
Inflation Reduction Act (8)
Influenza (57)
Intellectual property (101)
Interviews (510)
IPO (14732)
IRA (42)
Job creations (4036)
Job search strategy (1911)
Kidney cancer (11)
Labor market (37)
Layoffs (542)
Leadership (24)
Legal (7348)
Liver cancer (82)
Lung cancer (337)
Lymphoma (157)
Machine learning (9)
Management (59)
Manufacturing (333)
MASH (75)
Medical device (13279)
Medtech (13284)
Mergers & acquisitions (18826)
Metabolic disorders (769)
Multiple sclerosis (87)
NASH (21)
Neurodegenerative disease (112)
Neuropsychiatric disorders (31)
Neuroscience (2026)
NextGen: Class of 2025 (6761)
Non-profit (4852)
Now hiring (33)
Obesity (414)
Opinion (246)
Ovarian cancer (81)
Pain (101)
Pancreatic cancer (87)
Parkinson's disease (157)
Partnered (20)
Patents (231)
Patient recruitment (114)
Peanut (50)
People (54420)
Pharmaceutical (31)
Pharmacy benefit managers (21)
Phase I (20052)
Phase II (28193)
Phase III (21607)
Pipeline (1368)
Policy (165)
Postmarket research (2562)
Preclinical (7828)
Press Release (63)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (231)
Rare diseases (414)
Real estate (5691)
Recruiting (69)
Regulatory (22506)
Reports (36)
Research institute (2508)
Resumes & cover letters (414)
Rett syndrome (5)
RNA editing (4)
RSV (50)
Schizophrenia (79)
Series A (138)
Series B (91)
Service/supplier (9)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (156)
Sponsored (26)
Startups (3569)
State (1)
Stomach cancer (15)
Supply chain (72)
Tariffs (51)
The Weekly (57)
Vaccines (807)
Venture capitalists (44)
Weight loss (286)
Women's health (32)
Worklife (20)
Date
Today (32)
Last 7 days (873)
Last 30 days (2829)
Last 365 days (30530)
2025 (10986)
2024 (33074)
2023 (37837)
2022 (48493)
2021 (52902)
2020 (52608)
2019 (46512)
2018 (35736)
2017 (32330)
2016 (31337)
2015 (35416)
2014 (27071)
2013 (22252)
2012 (23986)
2011 (24759)
2010 (22068)
Location
Africa (927)
Alabama (56)
Alaska (7)
Arizona (175)
Arkansas (14)
Asia (38003)
Australia (6554)
California (6097)
Canada (1775)
China (514)
Colorado (267)
Connecticut (263)
Delaware (126)
Europe (87470)
Florida (841)
Georgia (192)
Hawaii (1)
Idaho (59)
Illinois (530)
India (26)
Indiana (308)
Iowa (9)
Japan (163)
Kansas (98)
Kentucky (26)
Louisiana (12)
Maine (68)
Maryland (854)
Massachusetts (3983)
Michigan (217)
Minnesota (362)
Mississippi (2)
Missouri (84)
Montana (26)
Nebraska (25)
Nevada (60)
New Hampshire (69)
New Jersey (1586)
New Mexico (30)
New York (1652)
North Carolina (934)
North Dakota (9)
Northern California (2622)
Ohio (191)
Oklahoma (13)
Oregon (34)
Pennsylvania (1229)
Puerto Rico (13)
Rhode Island (30)
South America (1284)
South Carolina (23)
South Dakota (1)
Southern California (2355)
Tennessee (101)
Texas (836)
United States (21796)
Utah (198)
Virginia (147)
Washington D.C. (63)
Washington State (532)
West Virginia (3)
Wisconsin (54)
638,702 Results for "nicox sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nicox Provides Full Year 2024 Financial Results
April 30, 2025
·
8 min read
Nicox’s Ordinary and Extraordinary Shareholders’ Meeting on May 6, 2024
Nicox SA, an international ophthalmology company, announced that the Ordinary and Extraordinary General Meetings were held today, on second convening.
May 6, 2024
·
3 min read
Business
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
Nicox SA, an international ophthalmology company, provided the revenue and cash position for Nicox SA and its subsidiaries for the first quarter of 2024 and financial results for Nicox SA for the full year of 2023, as approved by the Board of Directors on April 19, 2024, and provided an update on key future milestones.
April 22, 2024
·
10 min read
Press Releases
Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
March 19, 2025
·
3 min read
Business
Nicox Provides Fourth Quarter 2023 Financial and Business Highlights
Nicox SA provided financial and business highlights for the fourth quarter of 2023 for Nicox SA and its subsidiaries.
January 25, 2024
·
6 min read
Press Releases
Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
January 28, 2025
·
3 min read
Press Releases
Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights
January 21, 2025
·
6 min read
Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
Nicox SA, an international ophthalmology company, convenes an ordinary shareholder meeting on Friday June 28th, 2024 at 2:30 pm CEST in the offices of BuroClub – Drakkar 2 – Bâtiment D – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.
May 24, 2024
·
2 min read
Press Releases
Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected
December 2, 2024
·
6 min read
Business
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO
Nicox SA, an international ophthalmology company, announced its Board of Directors has appointed the highly experienced biotech executive Gavin Spencer as Chief Executive Officer.
February 28, 2024
·
5 min read
1 of 63,871
Next
